A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

Scientists in Shanghai have made a breakthrough in protein design by leveraging artificial intelligence, establishing the world's largest protein sequence dataset and developing models that enable ...

Experts recommend getting vaccinated. (There are currently three FDA-approved RSV vaccines, including GSK's AREXY vaccine.) The Centers for Disease Control and Prevention currently recommends the ...

Inpex chief executive, Takayuki Ueda, on Wednesday confirmed the company plans to start FEED studies in the middle of this year and then intends to sanction the development before entering the ...

no matter what the timeline looks like. In the meantime, the province will allow development permits in some exceptional cases, including repairs to existing critical infrastructure. Arsenault ...

The lawsuit alleged that Pfizer’s RSV vaccine, Abrysvo, violated GSK's patent rights in its competing RSV vaccine Arexvy. The companies said they would dismiss the case “with prejudice,” preventing it ...

Kawasaki has yet to devise a development timeline or plans for commercialization — although they suggest Robo-Colt could debut in the far-off year of 2050. Like a pony lover with a hobby horse ...

this would require the typical multiyear AI chip development timeline. However, Nvidia had a mechanism for post-manufacturing modification of its existing chip products. Specifically, each Nvidia chip ...

GSK filed suit in August 2023, alleging that Pfizer’s respiratory syncytial virus (“RSV”) vaccine, ABRYSVO, infringes four U.S. patents covering GSK’s rival RSV vaccine, AVREXY.

This robot is still very much a concept for now, however. Kawasaki representatives suggested it may be launched by 2050, but they have not announced any solid development timeline, and there are ...